OBJECTIVES: Care pathways are used widely in US healthcare settings and are expected to have greater influence on quality of care and patient outcomes in the future. We conducted qualitative research to evaluate the state of care pathways and their impact in the United States. STUDY DESIGN: Targeted literature review followed by an online survey and in-person interviews. METHODS: The PubMed and Cochrane databases were searched for publications on care pathways (January 1, 2005, to July 21, 2014) to inform the subsequent surveys and interviews with payers, providers, and pathway vendors regarding care pathway design, development, and management. A targeted hand search was completed in May 2015 to supplement the earlier review. RESULTS: Twenty-nine publications, posters, or abstracts on specific care pathways were identified; the online survey and follow-up interviews included 26 and 18 respondents, respectively. Positive trends in current care pathways development and implementation include prioritization of high-quality evidence, enhancing the role of providers in development and implementation, and flexibility for providers to tailor treatment decisions to patients' needs. Nevertheless, there are some limitations in methodology for development and implementation, in criteria for evaluation, and in the degree of transparency surrounding these activities. CONCLUSIONS: Our research confirms that high-quality evidence of efficacy and safety are expected to be central to future pathway development, and that physicians play a major role in development and implementation. To achieve the goals of improving quality of care while managing costs, further efforts are required regarding systematic development and evaluation, consistent implementation and compliance metrics, and transparency in implementation outcomes and financial motivators.
OBJECTIVES: Care pathways are used widely in US healthcare settings and are expected to have greater influence on quality of care and patient outcomes in the future. We conducted qualitative research to evaluate the state of care pathways and their impact in the United States. STUDY DESIGN: Targeted literature review followed by an online survey and in-person interviews. METHODS: The PubMed and Cochrane databases were searched for publications on care pathways (January 1, 2005, to July 21, 2014) to inform the subsequent surveys and interviews with payers, providers, and pathway vendors regarding care pathway design, development, and management. A targeted hand search was completed in May 2015 to supplement the earlier review. RESULTS: Twenty-nine publications, posters, or abstracts on specific care pathways were identified; the online survey and follow-up interviews included 26 and 18 respondents, respectively. Positive trends in current care pathways development and implementation include prioritization of high-quality evidence, enhancing the role of providers in development and implementation, and flexibility for providers to tailor treatment decisions to patients' needs. Nevertheless, there are some limitations in methodology for development and implementation, in criteria for evaluation, and in the degree of transparency surrounding these activities. CONCLUSIONS: Our research confirms that high-quality evidence of efficacy and safety are expected to be central to future pathway development, and that physicians play a major role in development and implementation. To achieve the goals of improving quality of care while managing costs, further efforts are required regarding systematic development and evaluation, consistent implementation and compliance metrics, and transparency in implementation outcomes and financial motivators.
Authors: Scott Haldeman; Claire D Johnson; Roger Chou; Margareta Nordin; Pierre Côté; Eric L Hurwitz; Bart N Green; Christine Cedraschi; Emre Acaroğlu; Deborah Kopansky-Giles; Arthur Ameis; Afua Adjei-Kwayisi; Selim Ayhan; Fiona Blyth; David Borenstein; O'Dane Brady; Peter Brooks; Connie Camilleri; Juan M Castellote; Michael B Clay; Fereydoun Davatchi; Robert Dunn; Christine Goertz; Erin A Griffith; Maria Hondras; Edward J Kane; Nadège Lemeunier; John Mayer; Tiro Mmopelwa; Michael Modic; Jean Moss; Rajani Mullerpatan; Elijah Muteti; Lillian Mwaniki; Madeleine Ngandeu-Singwe; Geoff Outerbridge; Kristi Randhawa; Heather Shearer; Erkin Sönmez; Carlos Torres; Paola Torres; Leslie Verville; Adriaan Vlok; William Watters; Chung Chek Wong; Hainan Yu Journal: Eur Spine J Date: 2018-08-27 Impact factor: 3.134
Authors: Deborah Tomlinson; Paula D Robinson; Paul Gibson; Melissa Beauchemin; Allison Grimes; Grace Dadzie; Mark Mairs; Erin Plenert; Emily Vettese; Stephanie Cox; L Lee Dupuis; Lillian Sung Journal: Support Care Cancer Date: 2022-06-22 Impact factor: 3.359
Authors: Gregory Hanson; Keith W Lyons; Debra A Fournier; S Scott Lollis; Eric D Martin; Kurt K Rhynhart; Wanda J Handel; Kevin J McGuire; William A Abdu; Adam M Pearson Journal: Global Spine J Date: 2019-03-05